ARG1 and neoplasm: Tumor-infiltrating dendritic cells (TIDCs) decrease the expression of CD3ζ in T cells through the action of ARG1, inducing anergy in CD8+ T cells and thereby promoting tumor progression (Norian et al. 2009).